The US Food and Drug Administration has issued an additional six warning letters in recent days on coronavirus claims. The letters coincide with an industry coalition raising a red flag on the growing flood of such claims on dietary supplement-type products.
Holland & Barrett staff have set up a petition, signed by thousands of staff and customers, begging the company to close its stores during the coronavirus pandemic as they argue their lives and the lives of customers are being put at risk.
A coalition of dietary supplement industry trade associations have come out in support of FDA actions against fraudulent coronavirus treatment claims and have urged retailers to not stock products with such claims on their labels.
The COVID-19 pandemic has seen a spike in demand for immunity-boosting products, but what scope is there for new and credible research to examine if nutra products have a role to play in helping tackle the crisis?
The UK’s advertising watchdog has dismissed claims made by a retailer stating its cannabidiol (CBD) pain relief patch could reduce chronic pain, anxiety and diabetes, pointing out the claims were medicinal.
A panel of science researchers has put up a list of key findings on the role of micronutrients in supporting the immune system, which firms can tap on to educate the consumers in light of the coronavirus outbreak.
A FANCL-funded RCT study has discovered that the ingestion of tea flower extract, mulberry leaf extract, and chitosan could reduce postprandial blood glucose and triglyceride levels in healthy subjects.
Contract manufacturer Icelandirect has announced it has achieved organic certification, the company announced recently, which is part of a trend of widening organic options with the dietary supplement industry.